Kineta Inc (KA)
0.5899
+0.03
(+5.15%)
USD |
NASDAQ |
May 03, 16:00
0.59
0.00 (0.00%)
After-Hours: 20:00
Kineta Research and Development Expense (Quarterly): 1.561M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.561M |
| September 30, 2023 | 1.909M |
| June 30, 2023 | 2.71M |
| March 31, 2023 | 2.843M |
| Date | Value |
|---|---|
| December 31, 2022 | 24.28M |
| September 30, 2022 | 2.605M |
| June 30, 2022 | 3.879M |
| March 31, 2022 | 4.023M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
1.561M
Minimum
Dec 2023
24.28M
Maximum
Dec 2022
5.476M
Average
2.776M
Median
Research and Development Expense (Quarterly) Benchmarks
| Ironwood Pharmaceuticals Inc | 35.68M |
| Ampio Pharmaceuticals Inc | 1.242M |
| NovaBay Pharmaceuticals Inc | 0.004M |
| Palatin Technologies Inc | 5.554M |
| iBio Inc | 1.535M |